FDA grants fast track status to NOVABRIDGE drug for gastric cancer
NovaBridge Biosciences (NASDAQ: NBP) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to givastomig, a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)